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SUMMARY
Combinations of ionic liquids (ILs) with antimicrobial compounds have been
shown to produce synergistic activities in model liposomes. In this study, imida-
zolium chloride-based ILs with alkyl tail length variations are combined with
commercially available, small-molecule antimicrobials to examine the potential
for combinatorial and synergistic antimicrobial effects on P. aeruginosa, E. coli,
S. aureus, and S. cerevisiae. The effects of these treatments in a human cell culture
model indicate the cytotoxic limits of ILs paired with antimicrobials. The analysis
of these ILs demonstrates that the length of the alkyl chain on the IL molecule is
proportional to both antimicrobial activity and cytotoxicity. Moreover, the ILs
which exhibit synergy with small-molecule antibiotics appear to be acting in a
membrane permeabilizing manner. Collectively, results from these experiments
demonstrate an increase in antimicrobial efficacy with specific IL + antimicrobial
combinations on microbial cultures while maintaining low cytotoxicity in a
mammalian cell culture model.
INTRODUCTION
Antibiotic molecules are considered integral components of modern medicine in that theWorld Health Organi-
zation (WHO) recommends 38 different antibiotics on their list of essential medicines (Who, 2019b). Similarly, the
WHOhas labeled200antibioticmolecules and formulations in theAWaReclassification foruseandapplication,
in the attempt tominimize the development of antibiotic resistancewhile preserving the usefulness of thesemol-
ecules in clinical settings (Who, 2019a). In theUnitedStates,methicillin-resistant strains ofStaphylococcus epider-
midis and Staphylococcus aureus have been a recent cause for concern, while totally drug-resistant strains of
tuberculosis have been found in Italy and Iran (Klevens et al., 2006; Mohajeri et al., 2014). Worldwide, the preva-
lence of antibiotic resistant pathogens found in infections hasbeenon the increase in both community and noso-
comial infections (Founou et al., 2017). Therefore, the discovery of new antimicrobial molecules or formulations is
necessary to help combat the threat of drug-resistant strains of bacteria.
Strategies for combating antibiotic resistant bacteria include a number of different approaches. The scien-
tific literature is replete with reports on novel molecules as antimicrobials including peptides, biomimetic
polymers, metals, quorum signaling inhibitors, enzyme inhibitors, and non-specific biocidal molecules
(Ashby et al., 2017; Capilato et al., 2017; Mosaei and Harbottle, 2019; Kamaruzzaman et al., 2019; Rozman
et al., 2019; Takahashi et al., 2017; Fordham et al., 2014; D’souza et al., 2020; Zhou et al., 2019; Shirley et al.,
2018). In parallel, many groups have focused on the understanding of how bacteria develop resistance to
antimicrobials. These studies have led to a deeper understanding of bacterial efflux pumps, bacterial
response and regulation of membrane composition, modification of the polysaccharide lipopolysaccha-
ride/lipoteichoic acid layer, and formation of biofilms (Li et al., 2015; Lazar et al., 2018; Lee et al., 2019b;
Schroeder and Stephens, 2016). One promising avenue to enhance antimicrobial efficacy is the use of ex-
isting antimicrobial compounds in combination with secondary compounds that can increase efficacy. Anti-
microbial efficacy can be enhanced by both (1) combinatorial interactions in which antibiotic plus second-
ary compound improves antimicrobial activity and even further (2) synergistic interactions in which the
combination of antibiotic plus secondary compound improves antimicrobial activity with a combined effect
greater than the sum effect of either compound acting independently.
In practice, this approach has been applied to a very limited degree clinically and continues to be explored
experimentally in the laboratory. One of the most widely used combinatorial formulations in clinical
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practice is amoxicillin with clavulanic acid, where amoxicillin is an inhibitor of peptidoglycan synthesis while
clavulanic acid inhibits the b-lactamase enzyme which degrades amoxicillin (Huttner et al., 2019). Similar
approaches combine two molecules which each independently exhibit antimicrobial activity and combine
the dosing for treatment (Montelongo-Peralta et al., 2019; Opalski et al., 2020). Many of these combinations
are designed such that the two antimicrobials act via different mechanisms, ideally each enhancing the ac-
tivity of the other. Despite these efforts, no clear best clinical practice has emerged globally, only very nar-
row spectrum, case-specific protocols. In the laboratory, several studies have begun to show promise in
combining compounds that enhance the ability of antimicrobials. Significant progress has been made
demonstrating synergistic interactions between the antibiotic tetracycline and a number of different sec-
ondary compounds including 2-aminoimidazoles, quercetin, and baicalin (Rogers et al., 2010; Qu et al.,
2019; Novy et al., 2011). Interestingly, all of these compounds’ primary synergist effect is likely due to
the ability of the compound to enhance antimicrobial entry into the cell.
One such class of molecules that have been shown to destabilize membranes with limited cytotoxic effects
is room temperature ionic liquids (RTILs) which are salts that exist in the liquid form, absent any solvent, at
room temperature (Welton, 1999; Yu et al., 2013). These molecules represent a special class of ionic liquid
(IL) which has generated recent significant interest in a wide range of potential applications. In general, ILs
are composed of an anion and cation pair which can often be mixed and matched, creating a vast array of
possible IL species. These compounds can often exhibit chemical properties such as low melting points,
negligible vapor pressure, and exceptional solvation potential. Furthermore, ILs have been extensively
studied in electrochemical applications, most frequently as components for energy storage devices (Wa-
tanabe et al., 2017). ILs have received attention as potential biomaterials that can be tuned (via changing
their molecular cations and anions) for various biomedical applications (Saha and Mukherjee, 2018;
Schroder, 2017; Fiebig et al., 2014). Moreover, ILs have been shown to both stabilize and destabilize protein
structures, enhance enzymatic activity, impact DNA structure, and exhibit sensitive protein interactions
(Itoh, 2017; Schroder, 2017; Jumbri et al., 2014). However, evidence in the literature indicates that not all
ILs behave similarly, and, not surprisingly, the effects on biomolecules are dependent on the molecular
identity of the components of the ILs.
The interactions between ILs in aqueous solution and lipid bilayer membranes have guided the develop-
ment of IL-based drug formulation and drug delivery applications (Egorova et al., 2017; Hanna et al., 2017;
Pendleton and Gilmore, 2015; Singh et al., 2015, 2016; Singh and Kang, 2015; Alves et al., 2013; Weaver
et al., 2010; Riduan and Zhang, 2013; Zakrewski et al., 2014; Zhang et al., 2009) and opened research ave-
nues for IL-based antibiotics and antibiotic-IL combinations. There have also been a number of reports
highlighting both experimental and computational studies on how ILs interact with lipid bilayers (Jing
et al., 2016; Yoo et al., 2014). Hydrophobic ILs can insert into lipid bilayers (Yoo et al., 2016; Gal et al.,
2012; Benedetto et al., 2014; Mikkola et al., 2015; Jeong et al., 2012; Gayet et al., 2011; Alves et al.,
2013; Rengstl et al., 2014; Zakrewski et al., 2014; Lim et al., 2015), leading to a bilayer reorganization
(Yoo et al., 2016; Benedetto et al., 2014; Kontro et al., 2016). ILs have also been incorporated with
enzyme-hydrolyzing groups, alkyl chains, and stable anions with reported antibacterial effects (Cole,
2012). Additionally, a tetracycline-based IL has been shown to insert into liposomemembranes with impor-
tant drug delivery and antibiotic implications (Alves et al., 2013). The highly recombinant nature of ILs
makes amenable to formulating ‘‘designer’’ reagents to treat specific cell types: rearranging both the anion
and cation can allow for highly specific, tailored applications in different organisms (Pendleton and Gil-
more, 2015). Previous studies demonstrated that ILs with imidazolium-based cations were successful in
permeating the membranes of bacteria, yeast, and red blood cells (Cook et al., 2019). Other ILs have
been shown to exhibit antimicrobial activity alone or impact the manner in which antimicrobials interact
with lipid bilayers (Raucci et al., 2018; Hanna et al., 2017). Additionally, micelle formation can occur in these
molecules through the interactions of the IL alkyl chains, which can influence the interactions with cellular
membranes (Jungnickel et al., 2008).
Future treatment for drug-resistant microbes might entail pairing existing antimicrobials with existing or
novel reagents to overall bolster drug efficacy. This could involve the pairing of two species in which
one molecule enhances the delivery of the other, one species prevents degradation/breakdown of the
other, or both acting on different targets in the bacterial cell. ILs are potential candidates for this combi-
natorial approach due to the mix-and-match compatibility of IL components and the increasing under-
standing of their significant ability to impact biomolecules in a tunable manner. A critical parameter in
ll
OPEN ACCESS
2 iScience 24, 101853, January 22, 2021
iScience
Article
utilizing these combinatorial approaches will be to identify the ability of ILs to enhance antimicrobial activ-
ity without increasing the cytotoxicity of combined treatments to the host. The work presented herein in-
vestigates the ability to pair specific room temperature imidazolium-based ionic liquids (RTILs) that contain
variable length alkyl chains with a panel of traditional small-molecule antimicrobials and antimicrobial pep-
tides. The date presented below highlight a subset of well-studied class of RTILs, 1-alkyl-3-methylimidazo-
lium, and all ILs used in this study are liquid at room temperature. Finally, the combinations of these RTILs +
antimicrobial compound were screened for their combined and synergistic antimicrobial efficacy against
gram-negative and gram-positive bacteria, yeast, and for toxicity against mammalian cells.
RESULTS
Critical micelle concentrations (CMCs) of ILs in combination with tetracycline
Previous work has demonstrated antimicrobial effects of ILs and a strong correlation between increased
alkyl chain length and minimal inhibitory concentration (MIC) (Cook et al., 2019; Ghanem et al., 2015). In
this study, we evaluated both the magnitude of this antimicrobial effect, as well the potential mechanism
of actions for 1-alkyl-3-methylimidazolium RTILs of differing in alkyl chain length (Figure 1A).
Possible candidate mechanisms for the antimicrobial effects of ILs include the ability of the IL to act as a
potential detergent and destabilize the cell membrane while an alternative hypothesis is that the amphi-
pathic nature of ILs may directly impact an associated antimicrobial compound through the formation of
micelles. Micelles are roughly spherical structures formed by amphiphilic molecules in which the nonpolar
portion of the molecule is buried at the interior of the structure while the polar portions are exposed, favor-
ably interacting with the aqueous milieu. Previous work has shown that some of these imidazolium ILs can
form micelles, and thus if antimicrobials affect the critical micelle concentration (CMC), it would inherently
impact the antimicrobial activity (Lee et al., 2019a). Using a fluorescence-based assay with the environmen-
tally sensitive fluorophore 1,6-Diphenyl-1,3,5-hexatriene (DPH), CMC of [OMIM]Cl and [DMIM]Cl was
measured in the absence or presence of various concentrations of tetracycline (Figures 1B and S1). In
this assay, DPH fluorescence intensity increases dramatically upon formation of micelles due to DPH par-
titioning into the nonpolar core of themicelle (Chattopadhyay and London, 1984). The data show that tetra-
cycline has minimal effect on the formation of micelles over a 100-fold concentration range tested
compared to the no tetracycline control for both RTILs examined. Thus, any effects of tetracycline in com-
bination with RTILs are likely due to true synergistic behavior rather than influence on micellar properties.
Variation in alkyl chain length correlates to microbial inhibition and permeability
Microbial inhibition and cell membrane permeabilizing effects were evaluated using 3-methylimidazolium
chloride RTILs of differing in alkyl chain length with four microbial strains (P. aeruginosa, E. coli, S. aureus,
Figure 1. Ionic liquids with various chain lengths determine critical micelle concentration
1-alkyl-3-methylimidazolium chloride ILs and their effect on critical micelle formation in the presence of antibiotics. (A)
Imidazolium chloride ILs with various alkyl chain lengths used to evaluate the (B) critical micelle concentrations of
imidazolium chloride-based ILs in combination with a broad range of tetracycline concentrations from 0-1ug/mL. Assays
are performed in triplicate, error bars .05 confidence intervals for relative fluorescence intensity are used.
See also Figure S1
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and S. cerevisiae). In agreement with other studies, baseline MIC experiments suggest that alkyl chain
lengths of 6, 8, and 10 exhibit independent antimicrobial effects with longer chain lengths exhibiting the
greatest inhibition across a variety of microorganisms (Table 1).
While the surfactant properties of ILs have been proposed to destabilize cellular membranes and thus elicit
antimicrobial properties, we specifically tested this in the case of 1-alkyl-3-methylimidazolium RTILs to
identify potential mechanisms of IL-induced microbial inhibition. Flow cytometry was used to measure
the microbial cell wall permeability in the presence of short duration IL exposure (30 min) through infiltra-
tion of propidium iodide into the cell. Propidium iodide, a DNA stain, will only enter into cells in which the
cell membrane is destabilized, and thus, bacterial or yeast cells exhibiting an increased fluorescent signal in
the PE channel (Ex. 488nm/Em. 575nm) indicate membranes which have been permeabilized. Comparing
the fluorescent signals between our positive control, cetrimonium bromide, and our sample of IL and cells,
we were able to calculate the percentage of permeability. Similar to the correlation withMIC values, there is
a direct correlation between longer alkyl chain lengths and greater bacterial cell permeability (Figure 2)
(Figures S1A and S1B). For those ILs which presented with an antimicrobial effect, [HMIM]Cl, [OMIM]Cl,
and [DMIM]Cl demonstrated a direct correlation between IL concentration, ability to inhibit bacterial
growth, and the ability to permeabilize cell membranes.
The combination of ILs with antimicrobials acts to lower the minimum inhibitory
concentration of a broad set of antimicrobial compounds
After establishing MIC and permeabilizing effects of ILs of varying (2-10 C) chain lengths, ILs were tested
which were shown to have a partial antimicrobial effect; [HMIM]Cl and [OMIM]Cl were both subsequently
evaluated for the combinatorial effects of ILs with addition of antimicrobials. Using a 96-well plate format,
P. aeruginosa, E. coli, S. aureus, and S. cerevisiae in liquid culture were treated with varying concentrations
of IL, antimicrobial, or both for 24 hr and then evaluated for growth by a plate reader at OD600 (Figure 3A).
In total, two ILs, [HMIM]Cl and [OMIM]Cl, four microorganisms, and six antimicrobials were evaluated. Ev-
idence of a combined effect was considered positive when the addition of both IL and antimicrobial
demonstrated decreased bacteria cell growth in comparison to having IL or antimicrobial only. In one
representative example, S. cerevisiae was treated with chloramphenicol +/ [OMIM]Cl, and reduced cell
growth as seen by OD600 values was evident with both [OMIM]Cl + chloramphenicol when compared to
the effect of either independently (Figure 3B).
A broad range of screening experiments for combined effects of IL + antimicrobial were completed by
creating a matrix plate for each possible combination; data from each individual experiment were
compiled and analyzed to look for combined effects (Table 2). From the number of possible wells that could
potentially show combined effect, we calculated the percentage of those wells that showed the effect. In
general, a combined effect was present in many of the IL + antimicrobial combinations for both [HMIM]Cl
and [OMIM]Cl, in all four microorganisms, and with a wide range of antimicrobials. Out of the 48 possible
combinations, 33 (69%) plate assays evidenced at least one combination of IL + antimicrobial that demon-
strated enhanced antimicrobial efficacy in combination. Some combinations exhibited organism speci-
ficity, such as [HMIM]Cl and [OMIM]Cl + tetracycline yielding a strong combined effect in all three bacterial
strains tested while [HMIM]Cl and [OMIM]Cl + kanamycin dramatically enhanced efficacy in S. cerevisiae
only.
Ionic liquid S. aureus B. subtilis P. aeruginosa K. pneumoniae E. coli A. baumannii
[EMIM]Cl >100 >100 >100 >100 >100 >100
[BMIM]Cl 100 >100 >100 >100 100 100
[HMIM]Cl 12.5 50 25 25 6.25 12.5
[OMIM]Cl 1.25 5 10 5 1.25 5
[DMIM]Cl .31 .625 5 2.5 .31 1.25
Table 1. Inhibition of bacterial growth when treated with ILs is dependent on alkyl chain length
1-alkyl-3-methylimidazolium ILs with various alkyl chain lengths were used to evaluate the minimum inhibitory concentration (MIC) of these compounds on a va-
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Compiled results from this low-resolution screen of combinatorial effects of IL + antimicrobial indicate
combinatorial interactions are highly concentration dependent, suggesting that a potential synergistic ef-
fect is only present at specific concentrations of ILs or antimicrobials. In order to both validate these results,
as well as reproduce these findings at higher resolution, candidate combinations which elicited strong
combinatorial interactions where explored for the evidence of synergistic interactions at a finer range of
IL + antimicrobial concentrations. Specifically, the hypothesis was tested that there exist concentrations
of ILs which have no antimicrobial effect yet can still enhance the antimicrobial effectiveness of specific
antibiotics.
Targeted analysis of candidate IL + antimicrobial combinations at refined concentrations to
identify synergistic interactions
Several combinations of IL + antimicrobial demonstrated a synergistic interaction in microbial growth in-
hibition. Specifically, the combination of both [HMIM]Cl and [OMIM]Cl + tetracycline demonstrated a
strong synergistic effect for all three bacterial strains tested. Expanding on this result, P. aeruginosa and
S. aureus were treated with [HMIM]Cl and [OMIM]Cl + tetracycline for 24 hr in 96-well liquid culture plates
and evaluated for bacterial growth. All four treatments resulted in evident synergistic interactions of IL +
antimicrobial at multiple defined concentrations (Figures 4A–4D). While high concentrations of ILs or anti-
microbial compounds were sufficient to inhibit bacterial cell growth, at lower concentrations, the presence
of both IL + antimicrobial in combination yielded synergistic effect and a decrease in bacterial cell growth
as indicated by the boxed regions. Specifically, synergistic interactions are evident when IL has no apparent
antimicrobial effect, yet in combination with antimicrobial compound, a significant decrease in cell prolif-
eration is evident (Boxed regions Figures 4A–4D). Furthermore, the concentration-dependent effect of IL
on bacterial growth was additionally alkyl chain length dependent. The addition of [OMIM]Cl (Figures 4B
and 4D) elicited a decrease in the MIC of tetracycline at approximately 4-fold lower concentration for both
P. aeruginosa and S. aureus when compared to [HMIM]Cl (Figures 4A and 4C).
Combination of ionic liquid and antimicrobial in bactericidal disc assay
To further assess the combinatorial efficacy of these treatments, a bactericidal disc assay was performed,
and the results reaffirmed trends observed in liquid culture assays for an expanded set of antimicrobial
compounds. Addition of 6-mm cellulose discs soaked in solubilized antimicrobials to the plates allowed
for the creation of zones of inhibition (ZOIs) for the ten antimicrobials evaluated: kanamycin, tetracycline,
chloramphenicol, ampicillin, polymyxin B, doxycycline hyclate, clindamycin, azithromycin, melittin, and
linezolid. In the assay, four increasing concentrations of [HMIM]Cl (0, 0.0025, 0.00625, 0.025M) were chosen
Figure 2. Increasing alkyl chain length correlates with microbial permeability
Permeabilizing effects of ILs at increasing concentrations on P. aeruginosa as measured by flow cytometry following a
30-min IL exposure and PI staining. Percentage of cells positive for PI staining indicated on the y axis, error bars .05
confidence intervals for triplicate treatments are used.
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based on 96-well MIC liquid assays and added to LB agar plates prior pouring. After solidification, S. aureus
was plated onto the plates, antimicrobial soaked discs were added, and plates were grown overnight
before recording ZOIs. Digital pictures were acquired of all plates, and measurements of ZOI diameter
were performed using Adobe Illustrator (Figure 5A). The negative control phosphate buffered saline
(PBS) demonstrated no zone of inhibition, while the antibiotics diffused from the antimicrobial disc into
the surrounding media and inhibited bacterial cell growth in a surrounding ring. Digital pictures were taken
for all combinations of antimicrobial and [HMIM]Cl concentration (0, 0.0025, 0.00625, 0.025 M). Notably,
0.025M [HMIM]Cl was completely lethal to all S. aureus which was evidenced as a complete lack of growth
on plates even after several days in the incubator. Using the formula ((ZOI-PBS)/total plate diameter), we
calculated the relative ZOI score for each antimicrobial for all different [HMIM]Cl concentrations. The
data represented both numerically, as well as by shading, demonstrate a similar pattern to the liquid
MIC screen on 96-well plates (Figure 5B). Out of the six antimicrobials evaluated by both methods, only
ampicillin demonstrated conflicting results with a demonstrated synergistic interaction on plates and
only limited potential synergistic interaction with [OMIM]Cl in liquid culture. Overall, results with ILs + tetra-
cycline demonstrate strong and reproducible synergistic interactions. The combination of tetracycline plus
[HMIM]Cl yielded larger diameter ZOI with an initial score of 22.7 at OM and increasing to 23.9 and 28.3
with 0.0025M and 0.00625M [HMIM]Cl suggesting an increase of 5.3% and 24.7%, respectively, in
Figure 3. Combination of antimicrobial compoundswith IL leads to enhanced lethality in a wide range ofmicrobes
and antimicrobials
Combinations of antimicrobials with IL of various alkyl chain lengths on 4 different microorganisms demonstrate
increased antimicrobial effects with different classes of antimicrobials and ILs
(A) 96-well MIC plate setup with decreasing IL concentration from left to right and decreasing antibiotic concentrations
from top to bottom.
(B) Representative initial screen conducted with 1/2 plate setup S. cerevisiae, chloramphenicol, and [OMIM]Cl. Yellow
(antibiotic only), blue (IL only), green (combination IL + antibiotic), dark green (combination IL + antibiotic) indicating
decreased bacterial growth due to combined interaction. Numerical values presented are (OD600 readings) from 96-well
plate of 24-hr liquid bacterial culture indicating growth (high values) or limited growth (low values)
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antimicrobial potency. These data are further reflected when looking at IL + doxycycline, a close relative of
tetracycline, with an effective increase of 7.3% and 17.0% increase in 0.0025M and 0.00625M [HMIM]Cl,
respectively (Figure 5B).
Ionic liquid and antimicrobial cytotoxic effects on human cells
In order to understand the degree to which 1-alkyl-3-methylimidazolium of varying chain length is toxic to
human cells, we treated HeLa cells with ILs or ILs + tetracycline for 24 hr and evaluated cytotoxicity.
Following 24 hr of exposure in liquid culture at defined concentrations in a 96-well plate format, cells
were evaluated for viability using CellTiter-Blue assay in which living cells are able to metabolize resazurin
into resorufin, a fluorescent reporter molecule detected by plate spectroscopy. Consistent with findings for
bacteria and yeast microorganisms, high concentrations of imidazolium chloride-based ILs are toxic to
Antibiotic Organism [HMIM]Cl [OMIM]Cl
Chloramphenicol S. cerevisiae 7.14 14.29
S. aureus 14.29 0.00
E. coli 0.00 14.29
P. aeruginosa 10.71 7.14
Ampicillin S. cerevisiae 7.14 14.29
S. aureus 0.00 10.71
E. coli 0.00 7.14
P. aeruginosa 0.00 7.14
Kanamycin S. cerevisiae 32.14 28.57
S. aureus 0.00 0.00
E. coli 0.00 0.00
P. aeruginosa 14.29 0.00
Polymyxin B S. cerevisiae 7.14 7.14
S. aureus 14.29 7.14
E. coli 0.00 21.43
P. aeruginosa 0.00 7.14
Tetracycline S. cerevisiae 10.71 0.00
S. aureus 14.29 21.43
E. coli 10.71 7.14
P. aeruginosa 21.43 21.43
Ketoconazole S. cerevisiae 7.14 0.00
S. aureus 0.00 21.43
E. coli 21.43 21.43
P. aeruginosa 10.71 14.29
Table 2. Bacterial growth in liquid culture was evaluated for 6 different antimicrobial compounds in combination
with 2 different ILs in 4 different microorganisms
Results presented indicate the percentage of wells in which a combined interaction between IL + antimicrobial was evident as
decreased OD600 compared to IL or antimicrobial only (dark green in Figure 3B), cells highlighted darker blue with higher
percentage of cells displaying combined interaction. The percentage of wells yield reduced cell growth with combinations of
[HMIM]Cl or [OMIM]Cl + antimicrobial.
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HeLa cells (Figure 6A). Moreover, HeLa cells treated with ILs with longer alkyl chain lengths [OMIM]Cl are
less viable than when treated with [HMIM]Cl at the same final concentration.
When looking at the lethality of [HMIM]Cl or tetracycline independently on P. aeruginosa, low concentra-
tions of either show no lethality while at high concentrations, treatment is highly lethal to cells (Figure 6B).
Exposure to either [HMIM]Cl or tetracycline independently at concentrations of 0.05–0.025M or .01M,
respectively, yields approximately 50% lethality in P. aeruginosa. However, when combined at significantly
reduced concentrations of both molecules, similar 50% lethality is achieved. P. aeruginosa exhibits approx-
imately 50% lethality at tetracycline concentrations of < .002M with the addition of 0.0031M [HMIM]Cl.
The same combinatorial treatments were given to HeLa cells using [HMIM]Cl + tetracycline, and cells were
assayed for viability as previously described. As expected, in the absence of IL, the minimum concentration
of tetracycline required for cytotoxic effects was higher in HeLa cells (.05 mg/mL) compared to
P. aeruginosa (.002 mg/mL) (Figures 6B and 6C). Independently, treatment with [HMIM]Cl exhibited similar
cytotoxic and inhibitory effects at the same concentration in both HeLa cells and P. aeruginosa, demon-
strating 50% lethality at 0.05–0.025M [HMIM]Cl. However, in combination, [HMIM]Cl + tetracycline reduced
the amount of tetracycline required to reach 50% lethality in P. aeruginosa (Figure 6A) while at the same
time causing little to no increase in toxicity to human cells (Figures 6C and 6D). HeLa cells were treated
in triplicates with defined, non-cytotoxic concentrations of [HMIM]Cl, 0.0031M, 0.0062M, and 0.0125M,
in combination with a range of tetracycline concentrations. At concentrations of tetracycline below
.02 mg/mL, HeLa cells were not affected by the combination of the both IL + antibiotic. In contrast, a syn-
ergistic interaction between the IL + antibiotic reduces the concentration of antibiotic required to inhibit
P. aeruginosa at the same concentrations (Figure 6D).
DISCUSSION
The potential for ILs to act as a highly tunable antimicrobial agent has gained recent attention with a num-
ber studies demonstrating antimicrobial activity in a variety of microorganisms (Pendleton and Gilmore,
2015). However, while ILs have been shown to elicit antimicrobial activity and the mechanism of action
has begun to be explored, several key challenges must be overcome to identify whether ILs have potential
as therapeutic agents. In this study, we expanded on the potential mechanism of IL’s antimicrobial activity
Figure 4. Synergistic response with combinations of [HMIM]Cl or [OMIM]Cl + tetracycline on microbial lethality
Targeted analysis of synergistic interactions in combinations of antimicrobials with ILs. Conditional highlighting of MIC values (OD600 readings) from 96-well
plates of 24-hr liquid bacterial culture. Red represnts low growth and green represents high growth.
(A–D)(A) P. aeruginosa treated with [HMIM]Cl + tetracycline, (B) P. aeruginosa treated with [OMIM]Cl + tetracycline, (C) S. aureus treated with [HMIM]Cl +
tetracycline, (D) S. aureus treated with [OMIM]Cl + tetracycline. Boxes with thick borders represent wells demonstrating synergistic interactions. Regions
with dark highlighted borders indicate synergism as bacterial growth limited to a greater degree than the combined effect of either IL or antimicrobial.
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and importantly identified previously unknown combinatorial and synergistic interactions between imida-
zolium chloride-based ILs and a broad class of antimicrobial agents in a subset of microorganisms. Finally,
our results indicate that the enhanced toxic activity of combined IL + antimicrobial is only present in the
bacterial and yeast species we investigated and not in human cell lines which points to a potential use
as an adjuvant for antimicrobial treatments that may increase the efficacy of established medications by
expanding the therapeutic window of existing antimicrobials.
The combination of imidazolium chloride-based ILs with 6 and 8 carbon alkyl tails exhibit combined and
synergistic interactions with a wide range of antimicrobials. In two separate complementary assays, 96-
well liquid culture and zone of inhibition disc assays, the combination of ILs + antimicrobial was effective
in reducing the concentration of antimicrobial compound necessary to inhibit microbial growth (Figures 3,
4, and 5). Interestingly, while a surprisingly large number of different antimicrobials were enhanced by the
addition of IL, several trends point to specific modes of action for IL + antimicrobial synergy. One of the
strongest examples of combined effect was seen with the addition of IL + tetracycline which was evident
in multiple different assays. Moreover, the efficacy of doxycycline was also strongly enhanced in our ZOI
experiments. Both of these antibiotics are in the tetracycline family, an antibiotic class that inhibits protein
synthesis by targeting the 30S ribosomal subunit (Connell et al., 2003). Interestingly, it has been suggested
that the limited efficacy of tetracycline, as well as the mechanism for antibiotic resistance, revolves around
limited uptake and retention by bacterial strains (Reynard et al., 1971). Given the potential membrane de-
stabilizing effect of long alkyl chain ILs, it is reasonable to hypothesize that the addition of IL enhances the
ability of this class of antibiotics to enter and maintain higher concentrations within the bacterial cell. Alter-
natively, several of the ILs in this study have been demonstrated to induce stability changes in some soluble
proteins which could affect the ribosome stability or efflux pump activity(Kohn et al., 2018), although
studies on those specific protein systems have not been reported.
Similarly, we found complimentary results with the improved efficacy of kanamycin in S. cerevisiae. It is
typical practice in molecular biology to use the antibiotic kanamycin with bacteria and its analog geneticin
in yeast species despite the fact that the same neomycin resistance gene confers resistance to both anti-
microbials. Moreover, the primary structural difference between geneticin and kanamycin is the presence
of 2 additional methyl groups that confer increased hydrophobicity (Kaplan et al., 2016). Furthermore,
recent work indicates that the ability of kanamycin to enter cells is different in bacteria vs. eukaryotic cells
Figure 5. Bactericidal disc assays demonstrate combined effect of [HMIM]Cl or [OMIM]Cl + antimicrobial on
S. aureus growth
Bactericidal disc assays of S. aureus with addition of [HMIM]CL in combination with antimicrobials.
(A) Baseline representative growth plate – 150mm LB plate with S. aureus + 0M [HMIM]CL and 6-mm discs plus 15uL
indicated antimicrobial. Overlaid lines indicate the measured radius of the bacterial zone of inhibition (ZOI).
(B) Compiled results of various concentrations of IL + plus antimicrobial. The value represents the normalized radius of the
zone of inhibition relative total plate radius. Blue bars indicate percentage inhibition compared to 100% inhibition (no
growth) on .025M [HMIM]CL plate.
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and ultimately dependent on direct interactions of kanamycin with the cell membrane (John et al., 2017).
We posit that the historically evidenced reduced efficacy of kanamycin in S. cerevisiae may be the result
of inability of kanamycin to enter the cell, which in our hands, is significantly reduced when kanamycin is
combined with IL.
Amphiphilic molecules, such as ILs in this study, can act as antimicrobials in their own right, interacting with
the bacterial membrane in a detergent-like manner causing destabilization of the membrane(s) (Laatiris
et al., 2008). The activity of these molecules is linked to the monomer-micelle equilibrium, which dramat-
ically changes the physical and chemical properties of themolecule(s). Several lines of experiments point to
the ability of imidazolium chloride-based ILs to permeabilize cell membranes. In this study, we expand on
this concept by demonstrating that even short-term exposure of microbial cell populations leads to
enhanced uptake of propidium iodide (PI) into bacteria and yeast cells (Figure 2). Furthermore, previous
work has shown that some of these imidazolium ILs can form micelles, and thus, if tetracycline affects
the CMC, it would inherently impact the antimicrobial activity (Lee et al., 2019a). Micelle formation is pri-
marily governed by concentration, and the concentration at which micelles form is known as the CMC.
CMC has been shown to be influenced by salt concentration and other additives in solution (Palladino
and Ragone, 2011). Our results point to the fact that tetracycline does not significantly affect the ability
of [OMIM]Cl or [DMIM]Cl to form micelles (Figure 1B). One possible interpretation of this finding is that
Figure 6. Treatment of with ILs + tetracycline indicates specificity of combined effect for bacteria but not human
cell lines
The effects of ILs + tetracycline on human cell lines. HeLa cell lines grown in 96-well plates were exposed to IL only or IL +
tetracycline for 24 hr, and cell viability was assayed with Cell-titer blue
(A) HeLa cells treated with either [HMIM]Cl or [OMIM]Cl (no antibiotic) exhibit increasing cytotoxicity with increasing
concentration of IL (n = 3) .05 confidence intervals.
(B) Percentage lethality from 96-well plate assay P. aeruginosa grown with combined treatment of tetracycline + [HMIM]
Cl. IC50 of .0031M [HMIM]Cl + tetracycline indicated on chart by dashed line.
(C) Percentage cytotoxicity from 96-well plate assay HeLa cells grown with combined treatment of tetracycline + [HMIM]
Cl. IC50 of .0031M [HMIM]Cl + tetracycline indicated on chart by dashed line.
(D) Cell viability of HeLa cells with targeted concentrations of IL + tetracycline performed in triplicates. Green shading
indicates concentrations of tetracycline + [HMIM]Cl with limited cytotoxicity to HeLa cells. P. aeruginosa IC50 tetracycline
only or P. aeruginosa IC50 tetracycline +.0031M [HMIM]Cl indicated on chart by dashed line.
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tetracycline does not enhance the detergent-like properties of IL action on the cellular membrane but
rather the addition of [OMIM]Cl or [DMIM]Cl to microbial populations acts independently of antimicrobial
compound to elicit membrane destabilizing effects to enhance the efficacy of the antimicrobial compound
applied.
RTILs are often touted as biocompatible, non-toxic, and a green alternative; however, this classification is
likely only realistically applied in limited concentrations as some recent reports highlight the toxicity of
these classes of molecules (Pham et al., 2010). In an effort to understand how imidazolium chloride-based
ILs of varying chain length may be toxic to mammalian cells, we applied the combinatorial treatment of
IL + tetracycline to mammalian cells. Though a limited approximation, these assays with HeLa human cell
lines are a first step in identifying the potential human response to treatment using ILs + antibiotics
(Stepnowski et al., 2004). Principle among our findings was that while the combination of [HMIM]Cl +
tetracycline demonstrated a clear synergistic response as seen in the reduced amount of tetracycline
required to reach 50% lethality in P. aeruginosa (Figure 6B), the addition of [HMIM]Cl to HeLa cells
did not increase the toxicity of tetracycline in culture (Figure 6C). Taken together, our results suggest
that the combination of imidazolium chloride-based ILs with antimicrobials is capable of reducing the
amount of antibiotic necessary to combat bacterial growth while at the same time having little to no
additional toxic effect in human cell lines. The mechanism of action for why the apparent enhancement
of antibiotic delivery is effective in microbial cell populations but not mammalian cells is still unknown.
One potential biochemical explanation is that antibiotic action is regulated by internal cellular concen-
tration and that at typical treatment concentrations, microbes have a baseline ability to exclude or re-
move antibiotics. The addition of ILs can enhance the delivery and/or retention of antimicrobials to
both microbes and mammalian cells but due to the lack of specificity of antimicrobial targets in mamma-
lian cells, the toxicity of the antimicrobial is not increased. Future investigations will need to be per-
formed to assess the underlying mechanism that protects the mammalian cells from higher concentra-
tions of antibiotics while simultaneously eliciting a synergistic response in improving the efficacy of
antimicrobial compounds for combating bacterial growth.
Limitations of the study
The primary limitations of this study are due to the depth of comprehensive screens in the study to infer
relationships between efficacy of antimicrobial compound, IL, and microorganism being evaluated. In
this study, we tested 1-alkyl-3-methylimidazolium ILs with 5 different alkyl chain lengths in combination
with 10 different antimicrobial compounds for 4 different microorganisms. We are able to identify synergis-
tic interactions with 2 of the ILs with several different antimicrobials depending on the microorganism be-
ing evaluated. While specific trends are identified that suggest that the degree of synergism may be
enhanced for specific IL + antimicrobial compounds such as tetracycline + [HMIM]Cl), future work targeted
at identifying statistically significant correlations with broad classes of antimicrobials or microorganisms
will further aid understanding specific mechanisms of synergistic interactions.
Resource availablity
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, Benjamin R Carone (carone@rowan.edu)
Materials availability
This study did not generate new unique reagents.
Data and code availability
The data used for generation of figures in the current study are included in this publication; additional
data sets and original flow cytometry files that are not included and are supporting the current study
have not been deposited in a public repository and are available from the corresponding author on
request.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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A.J., Lämmerhofer, M., Kilpeläinen, I.,
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Figure S1 - (Related to Figure 1b) - Permeabilization of P. aeruginosa cell lines correlates 
with increasing concentrations of IL 
 
Figure S1 (Related to Figure 1b) 
Permeabilizing effects of ILs at increasing concentrations on A) S. aureus and B) E. coli as 
measured by flow cytometry following a 30 min IL exposure and PI staining. Percentage of cells 
positive for PI staining indicated on the y-axis, error bars .05 confidence intervals for triplicate 




Ionic Liquids (IL) 
Ionic liquids used in this study: 1-ethyl-3-methylimidazolium chloride, [EMIM]Cl, Sigma Cat# 
272841; 1-butyl-3-methylimidazolium chloride, [BMIM]Cl, Sigma Cat# 94128; 1-hexyl-3-
methylimidazolium chloride, [HMIM]Cl, Alfa Aesar Cat # H27178; 1-octyl-3-
methylimidazolium chloride, [OMIM]Cl, Alfa Aesar Cat # H59534; 1-octyl-3-
methylimidazolium chloride, ([DMIM]Cl), TCI Cat #D5351.  Solutions of IL at indicated 
concentration created with either PBS (Phosphate Buffer System) or water solvent as indicated 
by experiment.  
   
Critical Micelle Concentration (CMC) 
Stocks of 2 mM sodium phosphate buffer, 10 ug/mL Tetracycline, and 1.0 M {HMIM]Cl, 
[OMIM]Cl, and [DMIM]Cl were prepared. DPH concentration was determined by absorbance 
spectroscopy using ε350 = 88,000 (Chattopadhyay and London, 1984).  In a black, clear flat 
bottom 96-well plate, 50 uL of serially diluted IL was place in each well. Then, calculated 
amount of buffer was added to each well. Once all wells contained buffer and IL, appropriate 
amounts of tetracycline for final concentrations of 1 µg/mL, 0.1 µg/mL, 0.01 µg/mL, or 0 
µg/mL) was added to the wells. Right before measurement, DPH (final concentration 2.5µM) 
was added with gentle mixing by pipetting to ensure no bubbles were formed. Samples were 
measured using λex = 358 nm and λem = 430 nm.  Experiments were performed in triplicate 




Minimal Inhibitory Concentration (MIC) 
Bacteria were freshly streaked from frozen glycerol stock (-80oC) onto LB-Miller agar plates (E. 
coli D31 (Burman et al., 1968), S. aureus ATCC 35556, P. aeruginosa PA-01 (Capilato et al., 
2017), A. baumannii ATCC 19606, K. pneumoniae ATCC 700603, B. subtilis ATCC: 6051). A 
single colony was taken from each streak to prepare an overnight in fresh LB broth and placed 
into a shaking incubator set at 37C and 250 rpm for at least 18 hours. After 18 hours, a fresh 
dilution in LB Broth (1:200) was made and used for the experiment. Minimum Inhibitory 
Concentration (MIC) was performed using mid-log phase bacteria subsequently diluted to 5x105 
CFU/mL in the assay plate. The diluted culture was added to each well of a sterile 96-well plate 
containing serially diluted aliquots of each RTIL for a final volume of 100 µL. The plate was 
incubated at 37C overnight for about 18 hours. After 18 hours, the OD600 was measured using a 
Spectramax M5 multimode plate reader.  
 
 
Permeability Assay Flow Cytometry 
Microbial cultures (P. aeruginosa, E. coli, S. aureus,) were grown to mid-log phase, and 90μL of 
the bacterial culture added to 96-well. Prior to addition of IL, propidium iodide (PI) was added to 
each well at a final concentration of 2ug/mL.  Ionic liquids solutions in water ([EMIM]Cl, 
[BMIM]Cl, [HMIM]Cl, [OMIM]Cl, and [DMIM]Cl) were used in this assay. 10μL of ionic 
liquid solution was added to the 90μL of cells in each well for a total volume of 100μL, meeting 
the desired ionic liquid concentration (0.097, 0.196, 0.391, 0.781, 1.56, 3.13, 6.25, 12.5, 25, 50, 
and 100mM) for each well. For the positive control, cetyl-trimethyl-ammonium-bromide 
(CTAB) was used at a final concentration of 0.3M. Cells were exposed to IL for 30 mins and 
then analyzed for internal fluorescence using a BD FACSCelesta instrument using PE-594 




= Degree of Permeabilization.  
 
Bactericidal Disc Assay 
Assessment of bacterial growth on mixed media plates served as a clear visualization for the 
efficacy of the combinatory treatment of IL + antimicrobial.  Standard LB agar plates were 
prepared with the addition of increasing concentrations of [HMIM]Cl: 0, 0.0025, 0.00625, and 
0.025 M.  Plates were allowed to solidify and dry on bench for 24 hours before use.  300μL of S. 
aureus liquid culture at mid-log phase was plated evenly on each plate with sterile glass beads. 
Following addition of culture the plates allowed to dry for 30 minutes before the addition of 
antibiotic disc. During this period the discs were prepared from the stock solutions of solubilized 
antibiotics; 15μL of each of the 10 antibiotics used was pipetted onto a sterile 6mm cellulose disc 
(BD). Antibiotics used in this study, kanamycin (50 mg/mL), tetracycline (12.5 mg/mL), 
chloramphenicol (34 mg/mL), ampicillin (10mg/mL), polymyxin B (23 mg/mL), doxycycline 
hyclate (10 mg/mL), clindamycin (5 mg/mL), azithromycin (2.5 mg/mL), melittin (100 uM), and 
linezolid (5 mg/mL), fluconazole (5 mg/mL), ketoconazole (1 mg/mL). After plate drying was 
complete, sterile forceps were used to transfer the discs to the media and the plate was grown 
upright in an incubator overnight at 30°C. The following day, photographs were taken of the 
plates using iPhone 6 to visualize the zone of inhibition (ZOI) created by the combined 
treatment.  Final analysis of diameter of ZOI measures using Adobe Illustrator. 
 
Treatment with HeLa cells with ILs + tetracycline 
HeLa cells were grown and maintained in DMEM with 4.5 g/L glucose + Sodium Pyruvate + L-
Glutamine (VWRV02-0101) plus the addition of 10% FBS.   Growth media additionally contains 
Pen/Strep but prior to treatment with Ils, media was changed to exclude any antibiotics besides 
those being tested.  HeLa cells were grown to confluency in a T75 dish, dissociated with 3mL 
Trypsin/EDTA .05M for 3 min, and resuspended in 25 mL DMEM without antibiotics, 180μL 
cells/media were added to each of the 96 wells on the assay plate and incubated overnight. 
Solutions of [HMIM]Cl and [OMIM]Cl and tetracycline were created using PBS as a solvent and 
20 uL of IL or IL + tetracycline as added to 96-well plate and incubated for 24 hours.  All 
treatments on 96-well plates were performed in triplicate.  Cytotoxicity was evaluated using 
Promega CellTiter-Blue Cell Viability regent according to manufacturer’s guidelines. 20μL of 
CellTiter-Blue was added per well, then the plates were incubated for either 1, 2, or 4 hours read 
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